I am not sure which discussion this question belongs but as it is a future possible development I have chosen this one.
In sales forecasts the markets discussed are firstly USA followed by Europe, then some distance behind, Japan and China. The glaring untapped, potentially huge, market is the most populous country in the world, India. With the growing size of the middle class as GDP grows steadily, when do people think that India may start being a viable / important market for the types of drugs NEU is looking to develop? Does anyone know of India's approach to providing drugs for rare diseases which can be very highly priced?
NEU Price at posting:
$14.50 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)